Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 951–1,000 of 1,061 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06672653	Tolerance and Effectiveness of C14 on HPV Infection(PREPAP)	not yet recruiting	Phase 1 / Phase 2	66	MGB PharmaINDUSTRY	1	Nov 4, 2024	clinicaltrials
NCT06288373	Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC	recruiting	Phase 2 / Phase 3	440	Tongji HospitalOTHER	1	Oct 30, 2024	clinicaltrials